Align Technology: Attractive Entry After Q3 Beat And Multiple Compression

Align Technology (ALGN) is now rated Buy with a $180 target, offering ~10% upside after a significant correction and strong Q3 results. Q3 beat expectations: international demand and children's segment drove higher volumes, though average selling prices declined due to discounts and new markets. Adjusted operating margins improved to 23.9%, with aggressive buybacks and restructuring supporting EPS growth; GAAP margins impacted by one-time charges.

Seeking Alpha • Dec 12, 2025

Here's Why Align Technology (ALGN) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Dec 10, 2025

ALGN Stock Rises on Thailand Launch of Invisalign With MAOB

Align Technology's Thailand debut of Invisalign with MAOB lifts shares and expands its Class II treatment options for increasing patients.

Zacks Investment Research • Dec 9, 2025

Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction

BANGKOK--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced commercial availability in Thailand of the Invisalign System with mandibular advancement featuring occlusal blocks designed specifically to address Class II skeletal and dental correction by.

Business Wire • Dec 9, 2025

Align Technology, Inc. (ALGN) Presents at Evercore 8th Annual Healthcare Conference Transcript

Align Technology, Inc. (ALGN) Presents at Evercore 8th Annual Healthcare Conference Transcript

Seeking Alpha • Dec 3, 2025

Align Technology Showcases Digital Dentistry Innovations at Greater New York Dental Meeting 2025

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today shared highlights from its participation at the Greater New York Dental Meeting (GNYDM) 2025, one of the largest annual dental congresses in the United States. Align showcased its latest innovations in digital dentistry across the Align™ Digital.

Business Wire • Dec 3, 2025

Align Technology, Inc. (ALGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Align Technology, Inc. (ALGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Seeking Alpha • Dec 2, 2025

Align Technology (ALGN) Up 6.4% Since Last Earnings Report: Can It Continue?

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Nov 28, 2025

Here's Why Align Technology (ALGN) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Nov 25, 2025

Align Technology Recognized for the 3rd Time in Extel's 2025 All-America Executive Team Rankings, Including the Most Honored Company Distinction

TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced top-tier recognition in the 2025 All-America Executive Team rankings published by Extel Insights (formerly Institutional Investor Research), which evaluates.

Business Wire • Nov 26, 2025